your market intelligence analyst
Search Results
233 results
Your search is now limited to «Excipients» expert search.
PR Newswire 02/27/2020 04:00
- Submission based on data from the Phase III PRIMA clinical study that demonstrated clinically meaningful outcomes of niraparib maintenance treatment in the first-line setting regardless of biomarker status LONDON, Feb. 27, 2020 /PRNewswire/ -- GlaxoSmithKline plc announced that the...
More from PR Newswire:
The Excipients for Nutraceutical Oral Solid Dosage Forms report provides a detailed independent appraisal of the current and forecast demand of excipients for nutraceuticals by major products, supplier sales, dosage forms, and market trends and explores market opportunities and challenges for manufacturers of these excipients in the two largest regional markets of Europe and the US ...
More from Nutraceutical Business Review:
Seeking Alpha 02/25/2020 17:31
If you look at Life Sciences, this specialty excipient opportunity is really increasing.
More from Seeking Alpha:
Business Wire 02/25/2020 16:05
Revance’s lead product candidate, DaxibotulinumtoxinA for Injection (DAXI), combines a proprietary stabilizing peptide excipient with a highly purified botulinum toxin that does not contain human or animal-based components.
More from Business Wire:
The MAH also took the opportunity to update sections 2 and 4.4 of the SmPC to align with the updated annex of the guideline excipients with regards to sodium.
More from European Medicines Agency - EMEA (EU):
Guidance for Industry, Good Laboratory Practice Regulations Management Briefings, Post Conference Report, Aug 1979.
More from U.S. Food & Drug Administration - FDA - What's New: Drugs (FDA): 02/21/2020 01:45
Future work to enable drug product manufacture using FDM and PAM 3D printing technologies should include the suitability and characterization of polymers and other excipients amenable to processing.
More from
Manufacturing Chemist 02/20/2020 04:44
For Indena, contract development and manufacturing means offering and providing their customers with an ever-increasing breadth of high-quality services, explains Giusi Losi, Corporate Communication and Events.
More from Manufacturing Chemist:
When for excipient use and the maximum recommended daily dose of the medicine provides more than 1 mg of boron and the medicine is for internal use and/or oral application, the following warning statement is required on ...
More from Therapeutic Goods Administration (Australia): 02/19/2020 12:00
Condition : Advanced Malignant Solid Tumor Intervention : Drug: TQB3303 Sponsor : Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting.
More from
Kline Blogs 02/18/2020 10:48
This webinar is based on Kline’s just-published report covering Identifying Opportunities within the Nutraceutical Excipients for OSDFs Market. It will help you gain a general understanding of the consumption of nutraceuticals globally, but more importantly in the developed markets. the impact of these trends and emerging opportunities they create for ingredients suppliers in this complex […]. .
More from Kline Blogs:
(MENAFN - Ameliorate Solutions) The Rosuvastatin Calcium Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2026. Th...
More from Middle East North Africa Financial Network (MENAFN):
Primary Endpoint Achieved with High Statistical Significance. LAVAL, QC, Feb. 11, 2020 -- (Healthcare Sales & Marketing Network) – Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a commercial derm... Biopharmaceuticals, Drug Delivery, Dermatology Crescita Therapeutics, MMPE, plaque psoriasis.
More from Healthcare Sales & Marketing Network:
Contract Pharma 02/10/2020 10:26
ReForm Biologics LLC, a pharmaceutical technology company developing innovative platforms to improve biologic formulations and MilliporeSigma announced a global license agreement and collaboration to commercialize proprietary ReForm excipients used in biotherapeutic formulations.
More from Contract Pharma:

Chemicals - Agricultural

Chemicals - Industrial

Business Issues

Companies - Public

Companies - Venture Funded

Commodity Prices

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities


Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications